Abstract
This work was to demonstrate the relationship between serum 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), serum phosphorus (SP), and parathyroid hormone (PTH) and parathyroid function after central lymph node dissection (CLND) in patients with papillary thyroid carcinoma (PTC). 200 PTC patients after CLND were included, who were rolled into a control group (CG) (n = 89 cases without hypoparathyroidism) and an observation group (OG) (n = 111 cases with complicated hypoparathyroidism). The 1,25(OH)2D3, SP, and PTH levels were detected, and the diagnostic effect of these indicators was assessed. The serum PTH levels of patients in CG after surgery were normal relative to those before surgery, while the serum PTH of patients in OG was relatively lower. 1,25(OH)2D3 concentration of patients in OG was also inferior to CG, while the SP level was superior (P < 0.05). Hypoparathyroidism was positively correlated with serum PTH (r = 0.382) and 1,25(OH)2D3 (r = 0.321) and negatively correlated with SP (r = − 0.211). The area under the curve (AUC) (0.893), sensitivity (90.83%), and specificity (94.77%) of the joint diagnosis of 1,25(OH)2D3 + SP + PTH were greatly superior to those of the single diagnosis and the pairwise diagnosis with the three indicators (P < 0.05). Hypoparathyroidism in patients with PTC after CLND surgery was positively correlated with 1,25(OH)2D3 and PTH and negatively correlated with SP concentration. In addition, the combination diagnosis of 1,25(OH)2D3, PTH, and SP worked well.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12033-024-01147-0/MediaObjects/12033_2024_1147_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12033-024-01147-0/MediaObjects/12033_2024_1147_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12033-024-01147-0/MediaObjects/12033_2024_1147_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12033-024-01147-0/MediaObjects/12033_2024_1147_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12033-024-01147-0/MediaObjects/12033_2024_1147_Fig5_HTML.png)
Similar content being viewed by others
Data Availability
All data generated or analysed during this study are included in this published article.
References
Cauteruccio, M., Perna, A., Vitiello, R., Oliva, M. S., Pesare, E., Ziranu, A., & Merendi, G. (2020). A rare case of post-traumatic infected pilomatricoma of the finger of the hand diagnosed after performing radioiodine therapy. Journal of Biological Regulators and Homeostatic Agents, 34(3 Suppl. 2), 83–87.
Huang, X. C., Li, H. S., Hu, X. H., & Yi, T. H. (2020). Efficacy of carbon nanoparticles for parathyroid glands protection during total thyroidectomy and bilateral central lymph nodes dissection for thyroid cancer: A systematic review and meta-analysis. Acta Medica Mediterr, 38, 745–751.
M A. E. (2021). Preoperative thyroid-stimulating hormone associated risk of differentiated thyroid cancer in patients with thyroid nodules. Cellular and Molecular Biology (Noisy-le-Grand, France), 67(3), 85–91.
Kotanidou, E. P., Giza, S., Tsinopoulou, V. R., Margaritis, K., Papadopoulou, A., Sakellari, E., Kolanis, S., Litou, E., Serbis, A., & Galli-Tsinopoulou, A. (2023). The prognostic significance of BRAF gene analysis in children and adolescents with papillary thyroid carcinoma: A systematic review and meta-analysis. Diagnostics (Basel, Switzerland), 13(6), 1187.
Stergioula, A., Pantelis, E., Kormas, T., & Agrogiannis, G. (2023). Case report: Skeletal muscle metastasis from follicular thyroid carcinoma presenting as synovial sarcoma. Frontiers in Oncology, 13, 994729.
Paspala, A., Papakonstantinou, D., Pikoulis, E., Tomos, P., & Nastos, C. (2022). Synchronous sternal metastasectomy and total thyroidectomy for differentiated thyroid cancer: A rare case report. Cureus, 14(11), e31294.
Spaziani, E., Di Filippo, A. R., Di Cristofano, C., Caruso, G., Spaziani, M., Orelli, S., Fiorini, F., Picchio, M., & De Cesare, A. (2021). Incidental parathyroidectomy during total thyroidectomy as a possible risk factor of hypocalcemia. Experience of a single center and review of literature. Acta endocrinologica (Bucharest, Romania: 2005), 17(2), 207–211.
Kaul, P., Kaul, P., Poonia, D. R., Jakhetiya, A., Arora, V., & Garg, P. K. (2021). Risk Benefit analysis of routine thymectomy for differentiated thyroid cancers: A systematic review. Surgery journal (New York, N.Y.), 7(4), e307–e313.
Obongo Anga, R., Abbaci, M., Guerlain, J., Breuskin, I., Casiraghi, O., Marhic, A., Benmoussa-Rebibo, N., de Kermadec, H., Moya-Plana, A., Temam, S., Gorphe, P., & Hartl, D. M. (2023). Intraoperative autofluorescence imaging for parathyroid gland identification during total laryngectomy with thyroidectomy. Cancers, 15(3), 875.
Liu, X., Wong, C. K. H., Chan, W. W. L., Au, I. C. H., Tang, E. H. M., & Lang, B. H. H. (2022). Survival after hemithyroidectomy versus total thyroidectomy in non-high-risk differentiated thyroid cancer: Population-based analysis. BJS open, 6(6), zrac146.
Goodman, W. G., Ward, D. T., Martin, K. J., Drayer, D., Moore, C., Xu, J., Lai, J., Chon, Y., & Nemeth, E. F. (2022). Activation of the calcium receptor by calcimimetic agents is preserved despite modest attenuating effects of hyperphosphatemia. Journal of the American Society of Nephrology: JASN, 33(1), 201–212.
Zou, Y., Zhang, N., Tang, Y., Zhan, Z., Yang, M., Lu, Y., Li, G. S., & Zhang, L. (2021). Predictive markers for severe hypocalcemia in dialysis patients with secondary hyperparathyroidism after near-total parathyroidectomy. Annals of Palliative Medicine, 10(10), 10712–10719.
Delanaye, P., Lanot, A., Bouquegneau, A., Warling, X., Radermacher, L., Masset, C., Krzesinski, J. M., Moranne, O., & Cavalier, E. (2023). Monitoring 25-OH and 1,25-OH vitamin D levels in hemodialysis patients after starting therapy: Does it make sense? Clinica chimica acta; International Journal of Clinical Chemistry, 539, 50–54.
García Pascual, L., García González, L., Lao Luque, X., Palomino Meneses, L., & Viscasillas Pallàs, G. (2023). Evaluation of an early detection protocol, intensive treatment and control of post-surgical hypoparathyroidism in the first month after total thyroidectomy. Endocrinologia, diabetes y nutricion, 70(3), 202–211.
Song, J. L., Li, L. R., Xu, Z. L., Li, J. J., Sun, S. R., & Chen, C. (2022). Long-term survival in patients with papillary thyroid cancer who did not undergo prophylactic central lymph node dissection: A SEER-based study. World Journal of Oncology, 13(3), 136–144.
Chen, Y., Chen, S., Lin, X., Huang, X., Yu, X., & Chen, J. (2021). Clinical analysis of cervical lymph node metastasis risk factors and the feasibility of prophylactic central lymph node dissection in papillary thyroid carcinoma. International Journal of Endocrinology, 2021, 6635686.
Lin, H. Y., Tang, H. Y., Davis, F. B., Mousa, S. A., Incerpi, S., Luidens, M. K., Meng, R., & Davis, P. J. (2012). Nongenomic regulation by thyroid hormone of plasma membrane ion and small molecule pumps. Discovery medicine, 14(76), 199–206.
Sciacchitano, S., De Francesco, G. P., Piane, M., Savio, C., De Vitis, C., Petrucci, S., Salvati, V., Goldoni, M., Fabiani, M., Mesoraca, A., Micolonghi, C., Torres, B., Piccinetti, A., Pippi, R., & Mancini, R. (2022). Complete pseudo-anodontia in an adult woman with pseudo-hypoparathyroidism type 1a: A new additional nonclassical feature? Diagnostics (Basel, Switzerland), 12(12), 2997.
Baud, G., Jannin, A., Marciniak, C., Chevalier, B., Do Cao, C., Leteurtre, E., Beron, A., Lion, G., Boury, S., Aubert, S., Bouchindhomme, B., Vantyghem, M. C., Caiazzo, R., & Pattou, F. (2022). Impact of lymph node dissection on postoperative complications of total thyroidectomy in patients with thyroid carcinoma. Cancers, 14(21), 5462.
Godlewska, P., Benke, M., Stachlewska-Nasfeter, E., Gałczyński, J., Puła, B., & Dedecjus, M. (2020). Risk factors of permanent hypoparathyroidism after total thyroidectomy and central neck dissection for papillary thyroid cancer: A prospective study. Endokrynologia Polska, 71(2), 126–133.
Dawale, K., & Agrawal, A. (2022). Parathyroid hormone secretion and related syndromes. Cureus, 14(10), e30251.
Zhukov, A., Povaliaeva, A., Abilov, Z., Kovaleva, E., Usoltseva, L., Eremkina, A., Ioutsi, V., Dzeranova, L., Pigarova, E., Rozhinskaya, L., & Mokrysheva, N. (2022). Parameters of vitamin D metabolism in patients with hypoparathyroidism. Metabolites, 12(12), 1279.
**ang, Z., Wang, M., Miao, C., **, D., & Wang, H. (2022). Mechanism of calcitriol regulating parathyroid cells in secondary hyperparathyroidism. Frontiers in Pharmacology, 13, 1020858.
Chindris, A. M., Desai, K., Ozgursoy, S. K., Heckman, M. G., & Casler, J. D. (2023). A parathyroid hormone-guided calcium and calcitriol supplementation protocol reduces hypocalcemia-related readmissions following total thyroidectomy. Endocrine practice: Official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 29(4), 260–265.
Antoun, J., Williamson, D., Hubler, M., & Shoemaker, A. H. (2021). Calcitriol and Levothyroxine Dosing for Patients With Pseudohypoparathyroidism. Journal of the Endocrine Society, 5(12), bvab161.
Yao, L., Li, J., Li, M., Lin, C., Hui, X., Tamilselvan, D., Kandi, M., Sreekanta, A., Makhdami, N., Ali, D. S., Dandurand, K., Yang, K., Bilezikian, J. P., Brandi, M. L., Clarke, B. L., Mannstadt, M., Rejnmark, L., Khan, A. A., & Guyatt, G. (2022). Parathyroid hormone therapy for managing chronic hypoparathyroidism: A systematic review and meta-analysis. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research, 37(12), 2654–2662.
Van Uum, S., Shrayyef, M., M’Hiri, I., Dandurand, K., Ali, D. S., Bilezikian, J. P., Collins, M. T., Mannstadt, M., Rubin, M. R., Siggelkow, H., Tabacco, G., Tay, Y. D., Vokes, T., Winer, K. K., Yao, L., Guyatt, G., Rejnmark, L., & Khan, A. A. (2022). Initial assessment and monitoring of patients with chronic hypoparathyroidism: A systematic current practice survey. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research, 37(12), 2630–2641.
Acknowledgements
Not applicable.
Funding
The research is supported by: Hongmei Yu, Zhejiang Medical and Health Technology Project, Diagnosis of parathyroid function after central lymph node dissection and neck lymph node dissection using 1,25- (OH) 2-D3 combined with blood calcium and parathyroid hormone, respectively, (No.: 2023XY192). Weiwei Su, Zhejiang Medical and Health Technology Project, Thyroid surgery through the anterior margin of the lateral cervical sternocleidomastoid muscle approach, (No. 2023XY187).
Author information
Authors and Affiliations
Contributions
HY, HL, WS, ZX, MX, CH and XL analyzed data and writing, participated in collection of data and experimental operations, participated in design testing and supervision testing. All authors read and approve the manuscript version final.
Corresponding author
Ethics declarations
Ethics Approval and Consent to Participate
The study was approved by the local ethics committee of the Tongxiang First People’s Hospital. All experiments were performed in accordance with relevant guidelines and regulations such as the Declaration of Helsinki and the patients signed the informed consent form and agreed to be published.
Consent for Publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yu, H., Li, H., Su, W. et al. Correlation Between Serum 1,25(OH)2D3, Serum Phosphorus, and Parathyroid Hormone and Parathyroid Function After Central Lymph Node Dissection in Patients with Papillary Thyroid Carcinoma. Mol Biotechnol (2024). https://doi.org/10.1007/s12033-024-01147-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12033-024-01147-0